Location History:
- Belle Mead, NJ (US) (1988 - 1990)
- Belle Meade, NJ (US) (1999)
Company Filing History:
Years Active: 1988-1999
Title: Michiel E Ultee: Innovator in Macromolecule Protection
Introduction
Michiel E Ultee is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of macromolecule protection, particularly through his innovative methods and formulations. With a total of 3 patents, Ultee's work has had a substantial impact on pharmaceutical and biotechnological applications.
Latest Patents
Ultee's latest patents include groundbreaking inventions that focus on lyoprotection and antibody fragment conjugates. One of his notable patents is titled "Methods for lyoprotecting a macromolecule using tricine." This invention relates to lyoprotection agents that safeguard macromolecules during lyophilization or freeze-drying. The patent also describes lyophilized instant kit formulations for the radiolabeling of pharmaceuticals and macromolecules. Another significant patent is "Method for the preparation of antibody-fragment conjugates." This novel method outlines the preparation of soluble antibody fragment compositions that possess superior characteristics for targeted delivery when administered in vivo. These compositions maintain the same immunospecificity as the unconjugated antibody while ensuring aqueous solubility suitable for in vivo administration.
Career Highlights
Throughout his career, Michiel E Ultee has worked with prominent organizations such as Cytogen Corporation and New York University. His experience in these institutions has allowed him to develop and refine his innovative approaches to macromolecule protection and delivery.
Collaborations
Ultee has collaborated with several professionals in his field, including Vernon L Alvarez and Charlotte A Burton. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
In summary, Michiel E Ultee is a distinguished inventor whose work in macromolecule protection and antibody fragment conjugates has led to significant advancements in the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to improving therapeutic and diagnostic methods.